ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer

Obstetrics & Gynecology Hospital of Fudan University
ClinicalTrials.gov · Datasets · License: Public Domain
Open Source ↗
immunotherapyovariancancerpembrolizumab
ovarian cancer, immunotherapy, pembrolizumab
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 249581
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.